The Society for Women’s Health Research (SWHR) submitted comments in response to the recently released NIH-Wide Strategic Plan for COVID-19 […]
The Society for Women’s Health Research (SWHR) submitted comments in response to a newly released U.S. Food and Drug Administration […]
The Society for Women’s Health Research (SWHR) submitted comments as a follow-up to the U.S. Food and Drug Administration (FDA) […]
An Official Position Statement of the Society for Women’s Health Research POSITION Research must take into account sex as […]
SWHR signed on to a comment letter from the Coalition to Advance Maternal Therapeutics (CAMT) regarding the inclusion of pregnant […]
SWHR submitted comments on the U.S. Food and Drug Administration (FDA) Office of Women’s Health’s strategic priorities. SWHR celebrates the […]
SWHR provided comments as a follow-up to the U.S. Food and Drug Administration (FDA) public meeting regarding the proposed recommendations […]
SWHR provided comments to the National Institutes of Health (NIH) Advisory Committee to the Director Working Group on Enhancing Rigor, […]
SWHR President and CEO Kathryn Schubert, MPP, released the following statement in support of the Uterine Fibroids Research and Education […]
SWHR provided feedback on a white paper from Sen. Lamar Alexander, chair of the Senate Health, Education, Labor, and Pensions […]